NDC Product Labeler Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. labeler's code is 25682. The labeler has 17 products that have an assigned National Drug Code.
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Product Type | Status |
---|---|---|---|---|---|---|
25682-001 | Soliris | Eculizumab | Injection, Solution, Concentrate | Intravenous | Human Prescription Drug | ACTIVE |
25682-007 | Kanuma | Sebelipase Alfa | Injection, Solution, Concentrate | Intravenous | Human Prescription Drug | ACTIVE |
25682-010 | Strensiq | Asfotase Alfa | Solution | Subcutaneous | Human Prescription Drug | ACTIVE |
25682-013 | Strensiq | Asfotase Alfa | Solution | Subcutaneous | Human Prescription Drug | ACTIVE |
25682-016 | Strensiq | Asfotase Alfa | Solution | Subcutaneous | Human Prescription Drug | ACTIVE |
25682-019 | Strensiq | Asfotase Alfa | Solution | Subcutaneous | Human Prescription Drug | ACTIVE |
25682-022 | Ultomiris | Ravulizumab | Solution, Concentrate | Intravenous | Human Prescription Drug | ACTIVE |
25682-025 | Ultomiris | Ravulizumab | Solution, Concentrate | Intravenous | Human Prescription Drug | ACTIVE |
25682-028 | Ultomiris | Ravulizumab | Solution, Concentrate | Intravenous | Human Prescription Drug | ACTIVE |
25682-043 | Voydeya | Danicopan | Tablet, Film Coated | Oral | Human Prescription Drug | ACTIVE |
25682-046 | Voydeya | Danicopan | Kit | Human Prescription Drug | ACTIVE | |
25682-049 | Voydeya | Danicopan | Kit | Human Prescription Drug | ACTIVE | |
25682-031 | Ultomiris | |||||
69853-0101 | Andexxa | |||||
69853-0102 | Andexxa | |||||
69853-0201 | Bevyxxa | |||||
69853-0202 | Bevyxxa |